Compare Charles River Laboratories Intl. Inc (CRL) vs Godaddy Inc (GDDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Godaddy Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $231.68 (market cap $11.14B), while Godaddy Inc trades at $92.24 (market cap $12.06B). The key difference: Charles River Laboratories Intl. Inc and Godaddy Inc are close in size by market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Godaddy Inc nearer its low. Which is the better fit depends on your goals.
| CRL | GDDY | |
|---|---|---|
Market Cap | $11.14B | $12.06B |
Sector | Health | Technology |
52-Week High | $233.60 | $169.40 |
52-Week Low | $145.57 | $75.07 |
Enterprise Value | $14.00B | $14.65B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.
Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.
GoDaddy (GDDY) trades at $90.86, up 2.18% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The company shows robust fundamentals, including a 17.32% net income margin and a P/E of 14.4, while analyst consensus is a Buy with a $123 price target. However, recent news highlights a securities class action investigation, adding a layer of risk.
The outlook remains positive due to consistent earnings performance and solid cash flow, but investors should weigh the legal overhang and high debt levels against the stock's growth potential and attractive valuation multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Godaddy Inc
GoDaddy is a provider of domain registration and aftermarket services, website hosting, security, design, and business productivity tools, commerce solutions, and domain registry services. The company primarily targets micro- to small businesses, website design professionals, registrar peers, and domain investors. Since acquiring payment processing platform Poynt in 2021, the company has expanded into omnicommerce solutions, including offering an online payment gateway and offline point-of-sale devices.
Read more on GDDY →
